Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chaudhary E Ahmad"'
Autor:
Christopher O’Callaghan, Scott Berry, Petr Kavan, Jonathan M Loree, Felix Couture, Dongsheng Tu, Sheryl Koski, Lucy X Ma, Emma Titmuss, Derek J Jonker, Hagen F Kennecke, Chaudhary E Ahmad, John R Goffin, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoit Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Eric X Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 12 (2024)
Background Nutritional stress is a mechanism that allows tumor cells to evade the immune system. Arginine (ARG), an amino acid involved in immunomodulation, aids in regulating T-lymphocyte cell activity and the antitumor response. ARG deficiency in t
Externí odkaz:
https://doaj.org/article/049a1ab63a0c4bb59840eb50e1b906d5
Autor:
Lucy Xiaolu Ma, Jonathan M. Loree, Derek J. Jonker, Hagen Fritz Kennecke, Scott R. Berry, Felix Couture, Chaudhary E. Ahmad, John R. Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoit Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Sheryl L. Koski, Dongsheng Tu, Christopher J. O'Callaghan, Eric Xueyu Chen
Publikováno v:
Journal of Clinical Oncology. 41:183-183
183 Background: In response to energetic stress, colorectal cancer cells secrete creatine kinase brain-type (CKB). CKB converts creatine and ATP from the extracellular matrix to PC, which is imported intracellularly to sustain survival and metastatic
Autor:
Bruce Colwell, John R. Goffin, Hagen F. Kennecke, B. Samson, Félix Couture, Setareh Samimi, Tahir Abbas, Francine Aubin, Scott R. Berry, Alice C. Wei, Dongsheng Tu, Sheryl Koski, Nadine M Magoski, Petr Kavan, Chaudhary E. Ahmad, Jonathan M. Loree, Mohammed Harb, Christopher J. O'Callaghan, Nathalie Aucoin, Eric Chen, Derek J. Jonker
Publikováno v:
JAMA Oncology. 6:831
Single-agent immune checkpoint inhibition has not shown activities in advanced refractory colorectal cancer (CRC), other than in those patients who are microsatellite-instability high (MSI-H).To evaluate whether combining programmed death-ligand 1 (P
Autor:
Alice Chia-chi Wei, Félix Couture, Derek J. Jonker, Hagen F. Kennecke, Chaudhary E. Ahmad, Eric Chen, Jonathan M. Loree, Tahir Abbas, Christopher J. O'Callaghan, Mohammed Harb, Benoit Samson, Setareh Samimi, Scott R. Berry, John R. Goffin, Francine Aubin, Sheryl Koski, Dongsheng Tu, Bruce Colwell, Nathalie Aucoin, Petr Kavan
Publikováno v:
Journal of Clinical Oncology. 37:3512-3512
3512 Background: Targeting both PD-L1 and CTLA-4 may be synergistic immunotherapy approaches. CO.26 evaluated if dual inhibition leads to improved pt survival vs BSC alone in rmCRC. Methods: rmCRC pts were randomized 2:1 to D+T vs BSC. Treatment cons
Autor:
Eric Chen, Christopher J. O'Callaghan, Derek J. Jonker, Benoit Samson, Setareh Samimi, Tahir Abbas, Nathalie Aucoin, Nadine M Magoski, Alice Chia-chi Wei, Dongsheng Tu, Félix Couture, Bruce Colwell, Mohammed Harb, Francine Aubin, Sheryl Koski, Petr Kavan, Scott R. Berry, Hagen F. Kennecke, John R. Goffin, Chaudhary E. Ahmad
Publikováno v:
Journal of Clinical Oncology. 37:481-481
481 Background: D is a human monoclonal antibody (mAb) that inhibits binding of programmed cell death ligand 1 (PD-L1) to its receptor. T is a mAb against the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Targeting both PD-L1 and CTLA-4 may h
Autor:
T Hsu, Prosanto Chaudhury, S Snow, M. Vickers, Sean P. Cleary, S. Gray, J Siddiqui, S Girard, G. Martel, I Alruzug, T Ng, R. Goodwin, M Thirwell, M Dorreen, Laura A. Dawson, F Halwani, T Asmis, P Galiatsatos, E Tsvetkova, A Mahmud, J. J. Biagi, M Seal, E Ferland, Dominick Bossé, James Brierley, L Sideris, Bruce Colwell, B. Samson, C Cripps, Neil Kopek, A Alfakeeh, B Ward, R. Goel, L Robillard, Chaudhary E. Ahmad
Publikováno v:
Current Oncology
Volume 23
Issue 6
Pages 3394-614
Volume 23
Issue 6
Pages 3394-614
The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016 was held in Montreal, Quebec, 5&ndash
7 February. Experts in radiation oncology, medical oncology, surgical oncology, and infectious diseases involved in the managemen
7 February. Experts in radiation oncology, medical oncology, surgical oncology, and infectious diseases involved in the managemen